MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-08-2026
Oragenics Shares 2011-2026 | OGEN
Annual Shares Oragenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.16 M | 221 K | 2.25 M | 2.01 M | 1.94 M | 56.5 M | 42.3 M | 13 M | 4.93 M | 4.46 M | 3.67 M | 3.62 M | 2.88 M | 1.77 M | 572 K | 5.66 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 56.5 M | 221 K | 9.25 M |
Quarterly Shares Oragenics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.3 M | 1.56 M | 732 K | 18.2 M | 419 K | 218 K | 151 K | 3.5 M | 3.08 M | 2.36 M | 2.02 M | 2.2 M | 2.02 M | 1.95 M | 1.94 M | 2 M | 116 M | 116 M | 116 M | 103 M | 91.8 M | 59.7 M | 52.2 M | 46.1 M | 46.1 M | 46.1 M | 46.1 M | 30.6 M | 29.4 M | 11.9 M | 6.03 M | 4.99 M | 4.93 M | 4.93 M | 4.93 M | 4.92 M | 4.91 M | 49.1 M | 40.1 M | 40 M | 39.9 M | 36.4 M | 36.4 M | 36.2 M | 36.2 M | 36.2 M | 36.1 M | 36.1 M | 36 M | 27.5 M | 27.5 M | 27.5 M | 27.4 M | 23.8 M | 13.4 M | 6.45 M | 5.89 M | 5.68 M | 5.68 M | 5.89 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 116 M | 151 K | 27.2 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
38.7 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
4.73 M | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
117 M | $ 1.72 | 4.57 % | $ 201 M | USA |
 |
I-Mab
IMAB
|
220 M | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
66.4 M | $ 31.69 | 2.72 % | $ 2.1 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B | France |
 |
BioNTech SE
BNTX
|
242 M | $ 93.95 | 1.84 % | $ 22.7 B | Germany |
 |
AstraZeneca PLC
AZN
|
1.55 B | - | - | $ 96.9 B |  Britain |
 |
CRISPR Therapeutics AG
CRSP
|
89.9 M | $ 53.5 | 3.69 % | $ 4.81 B |  Schweiz |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
9.34 B | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
93.4 M | $ 2.66 | 0.38 % | $ 249 M | Israel |
 |
Abcam plc
ABCM
|
229 M | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
98.5 M | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
54.9 B | - | -18.52 % | $ 27.3 M | Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
45.7 M | $ 0.77 | 12.35 % | $ 35.2 M | Israel |
 |
Esperion Therapeutics
ESPR
|
208 M | $ 3.13 | 0.16 % | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
26.9 M | $ 32.21 | 2.94 % | $ 867 M | USA |
 |
Affimed N.V.
AFMD
|
120 M | - | -34.95 % | $ 21.5 M | Germany |
|
Forte Biosciences
FBRX
|
12.9 M | $ 22.24 | 1.37 % | $ 288 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
21.6 M | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
22.6 M | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
68.9 M | - | -7.31 % | $ 87 M | USA |
 |
Galectin Therapeutics
GALT
|
63.9 M | $ 2.76 | -1.25 % | $ 176 M | USA |
 |
Generation Bio Co.
GBIO
|
66.6 M | - | - | $ 344 M | USA |
 |
IMV
IMV
|
8.34 M | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | Israel |
 |
Grifols, S.A.
GRFS
|
680 M | $ 8.1 | 1.12 % | $ 5.51 B |  Spain |
 |
Hutchison China MediTech Limited
HCM
|
858 M | $ 11.87 | 1.06 % | $ 10.2 B | China |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.19 M | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
59.3 M | - | - | $ 384 M | Britain |
 |
Heron Therapeutics
HRTX
|
167 M | $ 0.91 | 2.56 % | $ 152 M | USA |
 |
Gracell Biotechnologies
GRCL
|
338 M | - | - | $ 3.37 B | China |
 |
Anika Therapeutics
ANIK
|
14.3 M | $ 14.86 | -0.2 % | $ 213 M | USA |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
3.17 M | - | 5.93 % | $ 314 M | Canada |
 |
InflaRx N.V.
IFRX
|
67.3 M | $ 2.62 | -4.45 % | $ 176 M | Germany |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.65 M | $ 3.33 | -3.2 % | $ 5.48 M | Israel |